Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/26 16:33 | 4/2/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Venker Eric | NC | DO | CEO | 1 | S.d | -343 | 24.10 | 0 | -14 | 20 | D | |||||||||||||||
3/20/26 16:11 | 3/18/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Van Tuyl Christopher | NC | O | GC | 1 | S | -72 | 24.97 | 0 | -3 | 147 | D | |||||||||||||||
2/27/26 16:07 | 2/25/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Gloria Melanie | NC | O | COO | 1 | S | -90 | 27.85 | 0 | -3 | 170 | D | |||||||||||||||
1/23/26 16:21 | 1/21/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NY | O | CTO | 1 | S | -51 | 26.03 | 0 | -2 | 198 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |